La depresión es un determinante mayor de la capacidad funcional en pacientes con artritis reumatoidea, independientemente de la actividad de la enfermedad

  • Carolina Ayelen Isnardi Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
  • Dafne Capelusnik Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
  • Emilce Edith Schneeberger Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
  • Marcela Bazzarelli Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina
  • Laura Barloco Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina
  • Eliana Blanco Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
  • Cristian Alejandro Benítez Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
  • Federico Luján Benavídez Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
  • Santiago Scarafia Instituto de Asistencia Reumatológica Integral, Buenos Aires, Argentina
  • María Alicia Lázaro Instituto de Asistencia Reumatológica Integral, Buenos Aires, Argentina
  • Rodolfo Pérez Alamino Hospital de Clínicas Nicolás Avellaneda, Tucumán
  • Francisco Colombres Hospital de Clínicas Nicolás Avellaneda, Tucumán
  • María Paula Kohan Hospital General de Agudos Dr. Enrique Tornú, Ciudad Autónoma de Buenos Aires, Argentina
  • Julia Sosa Hospital General de Agudos Dr. Enrique Tornú, Ciudad Autónoma de Buenos Aires, Argentina
  • Luciana González Lucero Hospital Ángel C. Padilla, Tucumán, Argentina
  • Ana Lucía Barbaglia Hospital Ángel C. Padilla, Tucumán, Argentina
  • Hernán Maldonado Ficco Hospital San Antonio de Padua, Córdoba, Argentina
  • Gustavo Citera Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
Palabras clave: depresión, PHQ-9, Artritis Reumatoidea

Resumen

La depresión es una de las comorbilidades más frecuentemente reportadas en pacientes con Artritis Reumatoidea (AR). Su presencia se asocia a mayores costos de salud, mayor mortalidad y reduce las probabilidades de alcanzar una buena respuesta al tratamiento. Objetivo: evaluar la prevalencia de depresión en pacientes argentinos con AR y establecer su relación con diferentes factores sociodemográficos y clínicos. Material y métodos: se incluyeron pacientes ≥18 años de edad, con diagnóstico de AR según criterios ACR-EULAR 2010. Se consignaron datos sociodemográficos, comorbilidades, características clínicas, actividad de la enfermedad y tratamiento actual. Se administraron los cuestionarios EQ-5D-3L, QOL-RA, HAQ-A y PHQ-9. Los valores de PHQ-9 de 5-9, 10-14, 15-19 y ≥20 determinan la presencia de depresión leve, moderada, moderada/severa y severa, respectivamente y un valor de corte ≥10, depresión mayor. Análisis estadístico: Test T de Student, ANOVA y Chi2. Regresión lineal múltiple.

Citas

I. van ‘t Land H, Verdurmen J, Ten Have M, van Dorsselaer S, Beekman A, de Graaf R. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J Psychosom Res 2010;68(2):187-93.

II. Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol 2016;12(9):532-42.

III. Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2018;70(7):970-8.

IV. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013;52(12):2136-48.

V. Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab 2005;90(5):2522-30.

VI. . Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003;19(4):183.

VII. Beurel E, Lowell JA. Th17 cells in depression. Brain Behav Immun. 2018;69(5):28-34.

VIII. Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013;246(29):199-29.

IX. Guelfucci F, Kaneko Y, Mahlich J, Sruamsiri R. Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data. Rheumatol Ther 2018;5(1):171-83.

X. Ang DC, Choi H, Kroenke K, Wolfe F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32(6):1013-9.

XI. Boer AC, Huizinga TWJ, van der Helm-van Mil AHM. Depression and anxiety associate with less remission after 1 year in rheumatoid arthritis. Ann Rheum Dis 2019;78(1):e1. doi: 10.1136/annrheumdis-2017-212867.

XII. Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 2017;76(11):1906-10.

XIII. Strand V, Miller P, Williams SA, Saunders K, Grant S, Kremer J. Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry. Rheumatol Ther 2017;4(2):489-502.

XIV. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6(4):278-96.

XV. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4(6):561-71.

XVI. Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurements 1977;3(1):385-401.

XVII. Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-13.

XVIII. Siu AL, and the US Preventive Services Task Force (USPSTF). Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315(4):380-7.

XIX. Wittkampf KA, Naeije L, Schene AH, Huyser J, van Weert HC. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psychiatry 2007;29(5):388-95.

XX. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med 2007;22(11):1596-602.

XXI. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 2010;69(9):1589-95.

XXII. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990;16(3):199-208.

XXIII. Isnardi CA, Capelusnik D, Schneeberger EE, Bazzarelli M, Barloco L, Blanco E, et al. Validación del índice QOL-RA (Quality of Life-Rheumatoid Arthritis) en una cohorte Argentina de pacientes con Artritis Reumatoidea. Rev Argent Reumatolg 2018;29(1):19-25.

XXIV. Citera G, Arriola M, Maldonado-Cocco J, Rosemffet M, Sánchez M, Goñi M, et al. Validation and crosscultural adaptation of an Argentine spanish version of the health assessment questionnaire disability index. J Clin Rheumatol 2004;10(3):110-5.

XXV. Prevoo M, van‘t Hof M, Kuper H, van Leeuven M, van de Putte L, van Riel P. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38(1):44-8.

XXVI. Aletaha D, Nell V, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7(4):R796-806.

XXVII. Smolen J, Breedveld F, Schiff M, Kalden J, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003;42(2):244-57.

XXVIII. Curet A, Rillo O, Chaparro del Moral R, Papasidero S, Citera G, Maldonado Cocco JJ, et al. Modificación y aplicación de un índice de actividad simplificado (IAS) en pacientes con artritis reumatoidea. Rev Argent Reumatol 2005;16(1):13.

XXIX. Ambriz Murillo Y, Menor Almagro R, Campos-González ID, Cardiel MH. Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a General Hospital in Mexico. Reumatol Clin 2015;11(2):68-72.

XXX. Mella LFB, Bértolo MB, Dalgalarrondo P. Depressive symptoms in rheumatoid arthritis. Brazilian Journal of Psychiatry 2010;32(3):257-63.

XXXI. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depresión en artritis reumatoide. Rev Colom Reumatol 2017;24(2):84-91.

XXXII. Jacob L, Rockel T, Kostev K. Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom. Rheumatol Ther 2017;4(1):195-200.

XXXIII. Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis Care Res 2018;70(7):970-8.

XXXIV. Escalante A, del Rincón I, Mulrow CD. Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res 2000;13(3):156-67.

XXXV. Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 2011;6(6):617-23.

XXXVI. Margaretten M, Barton J, Julian L, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011;63(2):240-6.

XXXVII. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016;75(1):3-15.

XXXVIII. Katz PP, Barton J, Trupin L, Schmajuk G, Yazdany J, Ruiz PJ, et al. Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Outcomes in Rheumatoid Arthritis. Arthritis Care Res 2016;68(5):621-8.

XXXIX. Margaretten M, Barton J, Julian L, Katz P, Trupin L, Tonner C, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res 2011;63(2):240-6.

XL. Žagar I, Delimar V, Pap M, Perić D, Laktašić Žerjavić N, Perić P. Prevalence and Correlation of Depressive Symptoms with Functional Scores, Therapy and Disease Activity among Croatian Patients with Rheumatoid Arthritis: A Preliminary Study. Psychiatr Danub 2018;30(4):452-8.

XLI. Soósová MS, Macejová Ž, Zamboriová M, Dimunová L. Anxiety and depression in Slovak patients with rheumatoid arthritis. J Ment Health 2017;26(1):21-7.

XLII. Baerwald C, Manger B, Hueber A. Depression as comorbidity of rheumatoid arthritis. Z Rheumatol 2018 doi: 10.1007/s00393-018-0568-5.

XLIII. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/pages/news/news/2012/10/depression-in-europe/depression-definition

XLIV. Kronisch C, McLernon DJ, Dale J, Paterson C, Ralston SH, Reid DM, et al. Brief Report: Predicting Functional Disability: One-Year Results From the Scottish Early Rheumatoid Arthritis Inception Cohort. Arthritis Rheumatol 2016;68(7):1596-602.

XLV. Karpouzas GA, Draper T, Moran R, Hernandez E, Nicassio P, Weisman MH, et al. Trends in Functional Disability and Determinants of Clinically Meaningful Change Over Time in Hispanic Patients With Rheumatoid Arthritis in the US. Arthritis Care Res 2017;69(2):294-8.

XLVI. Matcham F, Ali S, Irving K, Hotopf M, Chalder T. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord 2016;11(3);17:155.

XLVII. Cordingley L, Prajapati R, Plant D, Maskell D, Morgan C, Ali FR, et al. Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis. Arthritis Care Res 2014;66(6):861-8.

XLVIII. Ton E, Bakker MF, Verstappen SM, Ter Borg EJ, van Albada-Kuipers IA, Schenk Y, et al. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis. J Rheumatol 2012;39(1):22-7.

XLIX. Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, van Eijk-Hustings, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther 2016;18(1):251.

L. Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006;60(6):631-7.

Publicado
2019-06-01
Cómo citar
1.
Isnardi CA, Capelusnik D, Schneeberger EE, Bazzarelli M, Barloco L, Blanco E, Benítez CA, Luján Benavídez F, Scarafia S, Lázaro MA, Pérez Alamino R, Colombres F, Kohan MP, Sosa J, González Lucero L, Barbaglia AL, Maldonado Ficco H, Citera G. La depresión es un determinante mayor de la capacidad funcional en pacientes con artritis reumatoidea, independientemente de la actividad de la enfermedad. Rev. Argent. Reumatol. [Internet]. 1 de junio de 2019 [citado 5 de julio de 2022];30(2):5 - 10. Disponible en: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/453
Sección
Artículo Original